# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-17-055814
Filing Date
2017-09-06
Accepted
2017-09-06 16:30:45
Documents
8
Period of Report
2017-09-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | a17-21323_18k.htm | 8-K | 23257
2 | EX-99.1 | a17-21323_1ex99d1.htm | EX-99.1 | 84231
3 | GRAPHIC | g213231mm11i001.jpg | GRAPHIC | 470146
4 | GRAPHIC | g213231mm03i001.jpg | GRAPHIC | 463490
5 | GRAPHIC | g213231mm01i001.jpg | GRAPHIC | 465442
6 | GRAPHIC | g213231mm07i001.jpg | GRAPHIC | 488231
7 | GRAPHIC | g213231mm09i001.jpg | GRAPHIC | 528004
8 | GRAPHIC | g213231mm05i001.jpg | GRAPHIC | 523471
| Complete submission text file | 0001104659-17-055814.txt |  | 4156242

Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS INC (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 171071668
SIC: 2834 Pharmaceutical Preparations